The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local ...

Purdue Pharma and the Sackler family have agreed to pay over $7 billion for their role in the opioid crisis. Norah O'Donnell Exits Ahead of Hard Pivot for ‘CBS Evening News' ...

which previously manufactured the drug OxyContin. While the Sackler family was once worth billions, this pending payment will require them to pay $6.5 billion over the course of 15 years ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not give Sackler family members immunity from future opioid lawsuits.

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

Members of the family who own OxyContin maker Purdue Pharma ... agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments ...

The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase ...

Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families." ...

“The Sackler family relentlessly pursued profit at the ... Purdue Pharma introduced 10mg prescriptions of OxyContin in 1996 and marketed it as a nonaddictive drug to treat daily pain.